Literature DB >> 31118491

MILD trial, strong confirmation of lung cancer screening efficacy.

Matthew B Schabath1, Denise R Aberle2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31118491     DOI： 10.1038/s41571-019-0231-3

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  4 in total

1.  Lung cancer screening: tell me more about post-test risk.

Authors:  Mario Silva; Gianluca Milanese; Ugo Pastorino; Nicola Sverzellati
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.

Authors:  U Pastorino; N Sverzellati; S Sestini; M Silva; F Sabia; M Boeri; A Cantarutti; G Sozzi; G Corrao; A Marchianò
Journal:  Eur J Cancer       Date:  2019-07-20       Impact factor: 9.162

Review 3.  Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

Authors:  Asha Bonney; Reem Malouf; Corynne Marchal; David Manners; Kwun M Fong; Henry M Marshall; Louis B Irving; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

4.  Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China.

Authors:  Jin Shi; Daojuan Li; Di Liang; Yutong He
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.